Literature DB >> 12410577

Pregnancy and successful labor in the course of chronic lymphocytic leukemia.

Günhan Gürman1.   

Abstract

Pregnancy and leukemia are difficult to manage. Protecting the mother from hemorrhage and infection and the fetus from developmental failure are the main aims. Chronic lymphocytic leukemia (CLL) has been seen very rarely with pregnancy. In this article, the successful labor of a 43-year-old woman with CLL is reported. She was not a candidate for chemotherapy at that time. She was without symptoms when she got pregnant. In the 30th gestational week she was found to have urinary tract infection and preterm labor and she was stabilized. Gestational diabetes and preeclampsia were also determined after that period and managed. The patient was delivered by cesarean section in the 39th gestational week. Cord blood was collected and preserved. No postpartum complication was seen in either the patient or the infant. This is one of the rare cases presenting CLL with pregnancy in the literature. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12410577     DOI: 10.1002/ajh.10216

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Chronic lymphocytic leukaemia in pregnancy: a case report and literature review.

Authors:  Cynthia Maxwell; Rosheen Grady; Michael Crump
Journal:  Obstet Med       Date:  2009-11-30

2.  CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.

Authors:  Dianne Pulte; Kim E Olson; M Johan Broekman; Naziba Islam; Harold S Ballard; Richard R Furman; Ashley E Olson; Aaron J Marcus
Journal:  J Transl Med       Date:  2007-05-04       Impact factor: 5.531

3.  Chronic lymphocytic leukaemia during pregnancy: management and thoughts.

Authors:  Patricia Winckler; Anna Vanazzi; Maddalena Bozzo; Giovanna Scarfone; Fedro A Peccatori
Journal:  Ecancermedicalscience       Date:  2015-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.